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AbsTrACT
Objective to investigate the carcinogenicity of styrene 
by reanalysing data from a previous international cohort 
study of workers in the reinforced plastics industry.
Methods Mortality from cancers of prior interest was 
analysed with more detailed consideration of exposure–
response relations and an updated classification of 
leukaemias and lymphomas in data from a previous 
international cohort study of 37 021 reinforced plastics 
workers exposed to airborne styrene.
results increased mortality from non-Hodgkin’s 
lymphoma (nHl) was associated with the mean level 
of exposure to styrene in air (relative risk (rr) 2.31, 
95% ci 1.29 to 4.12 per 100 ppm), but not with 
cumulative styrene exposure. Similar associations with 
mean exposure were observed for the oesophagus (rr 
2.44, 95% ci 1.11 to 5.36 per 100 ppm) and pancreas 
(rr 1.89, 95% ci 1.17 to 3.09). Oesophageal cancer 
mortality was also associated with cumulative styrene 
exposure lagged 20 years (rr 1.16, 95% ci 1.03 to 
1.31). no other cancer, including lung cancer, was 
associated with any indicator of styrene exposure.
Conclusion this reanalysis does not substantially 
change the conclusions of the original study with respect 
to nHl or lung cancer but new evidence concerning 
cancers of the oesophagus and pancreas merits further 
investigation.
InTrOduCTIOn
Styrene is a common industrial chemical that 
is produced worldwide in large volumes and is 
used in making plastic products, foams, resins 
and synthetic rubber.1 Occupational exposure to 
styrene can occur in industries producing or using 
it, while the population at large may be exposed to 
styrene at lower concentrations as a component of 
air pollution and of cigarette smoke and as a food 
contaminant.2 
Investigations into the potential carcinogenicity 
of styrene were prompted by reports in the 1970s 
and 1980s of excess leukaemia and lymphoma 
among workers in styrene production and polymer-
isation and styrene-butadiene rubber manufacturing 
facilities.3–6 Following these initial reports, further 
epidemiological studies focusing on cancers of the 
haematolymphatic system were undertaken in those 
industries (eg, refs.7–9) and in the reinforced plastics 
industry,10–12 where styrene exposures were high 
and few other known or suspected carcinogens 
were believed to be present.
Based on observations of positive associations 
between exposure to styrene and diverse cancers of 
lymphatic and haematopoietic tissues in several of 
these epidemiological studies and on experimental 
findings, styrene was subsequently classified as 
‘possibly carcinogenic to humans’ (group 2B) by the 
International Agency for Research on cancer2 and 
as ‘reasonably anticipated to be a human carcin-
ogen’ in the US Report on Carcinogens.13
Subsequent to those evaluations, further anal-
yses of several cohorts exposed to styrene have 
reported increased risks of other cancers, notably 
lung cancer.14–19 In addition, the understanding 
of the leukaemias and lymphomas has changed 
considerably, with multiple myeloma and the acute 
Key messages
What is already known about this subject?
 ► Styrene is classified as a possible carcinogen 
based on associations with leukaemia and 
lymphoma in previous studies.
 ► Recent studies suggest positive associations 
with several other cancers, including lung 
cancer.
What are the new findings?
 ► Among reinforced plastics workers, mortality 
from non-Hodgkin’s lymphoma was associated 
with career mean styrene exposure, but not 
with cumulative styrene exposure.
 ► Cancer of the oesophagus was significantly 
associated with cumulative and mean styrene 
exposure.
 ► Cancer of the pancreas was significantly 
associated with mean styrene exposure.
 ► Mortality from myeloid leukaemia was not 
significantly associated with any measure of 
styrene exposure, nor was lung cancer mortality.
How might this impact on policy or clinical 
practice in the foreseeable future?
 ► The carcinogenicity of styrene merits further 
investigation taking into account these new 
findings.
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and chronic lymphoid leukaemias now classified as subtypes of 
non-Hodgkin’s lymphoma (NHL).20
To investigate the extent to which leukaemia, NHL, as currently 
defined, and cancers of the lung and several other sites might 
be associated with occupational exposure to styrene, we rean-
alysed data from a large international cohort study of glass-re-
inforced plastics workers12 with a more detailed consideration 
of latency and exposure–response relations. The last analysis 
of this cohort published in 1994 showed a statistically signifi-
cant trend in mortality from all lymphatic and haematopoietic 
cancers combined with increasing mean, but not cumulative, 
styrene exposure and non-significant increases in mortality from 
malignant lymphoma, as then defined, with both cumulative and 
mean styrene exposure.12
MeTHOds
study population
In 1988, the International Agency for Research on Cancer (IARC) 
initiated a study of workers in the reinforced plastics industry in 
Denmark, Finland, Italy (two centres), Norway, Sweden and the 
UK (in the UK, two centres) to investigate associations between 
the risk of tumours of the lymphatic and haematopoietic systems 
and exposure to styrene. The study population and methods have 
been described elsewhere.12 Briefly, workers were enrolled from 
eight centres encompassing >600 plants. One cohort in the UK 
had been enumerated and analysed previously,9 and results from 
a separate analysis of the Danish cohort were published simul-
taneously with those of the full international study.21 In total, 
40 668 workers (34 560 men and 6128 women) were included 
and followed for cancer mortality. The follow-up period aver-
aged 13 years with the dates spanned varying among cohorts, 
from 1945 at the earliest to 1991 at the latest. In total, about 
3% of the cohort was lost to follow-up ranging from <1% in 
Finland to 7% in one UK centre.
Updated results for the Danish cohort and one British cohort 
based on extended follow-up have been published recently,16 17 
and we investigated the possibility of updating the follow-up for 
the other six cohorts. However, this proved to be infeasible prin-
cipally due to retirements of investigators and loss of records 
in several centres. In addition, new national privacy protection 
legislation prohibited the use of existing data from Norway, 
which had contributed 9% of person-time in the original cohort. 
Consequently, we reanalysed data from the cohort excluding 
Norway and did not add new mortality data from the two 
cohorts whose follow-up had been extended in order to avoid 
large variations in the time period of observation. Analysis 
files were reconstructed from the original data and errors were 
corrected in the process. 
Cancer mortality data
The previous analysis of the cohort focused on cancers of 
lymphatic and haematopoietic tissues, with detailed data 
presented for all such cancers combined, leukaemias and malig-
nant lymphomas, as defined in the 8th revision of the Interna-
tional Classification of Diseases (ICD). More limited analyses 
were reported for cancers of the lung, oesophagus, kidney and 
pancreas.12
To update the analysis, we regrouped ICD 8 and 9 codes from 
the original study to approximate the current WHO classifica-
tion of the lymphomas and leukaemias,20 as we did not have 
access to original diagnostic records (online supplementary table 
S1). Codes for lymphosarcoma and reticulosarcoma (200), other 
malignant neoplasms of lymphoid and histiocytic tissue (202), 
chronic lymphoid leukaemia (204.1) and multiple myeloma 
(203) were aggregated under the heading of NHL; there were 
no deaths in the cohort from acute lymphoid leukaemia, which 
is also considered to be a subtype of NHL. Acute and chronic 
myeloid leukaemia (ICD 8/9 205.0 and 205.1, respectively) were 
combined for analysis because of small numbers. This grouping 
was done independent of knowledge about exposure status of 
any individuals in the cohort.
In addition, we conducted internal exposure–response anal-
yses for the other specific cancers considered in the previous 
analyses and for cancers of the bladder and prostate, which 
showed positive associations in several recent studies14–19 22 and 
had at least 10 deaths among exposed workers.
exposure assessment
The study plants, most of which were small, produced a variety 
of reinforced plastic products including boats, tanks, containers, 
panels and small pieces, such as helmets, by laminating fibres with 
resins containing styrene. Workers were assigned to mutually 
exclusive groups based on their longest-held jobs. Laminators, 
production workers with mixed tasks or in small plants with no 
fixed job titles and workers who regularly entered areas where 
styrene was handled but were not involved in manual lamination 
were classified as exposed to styrene. Other manual and clerical 
personnel who worked in the industry but were not regularly 
exposed to styrene were classified as unexposed. The duration 
of exposure was estimated as the time employed in exposed jobs, 
which may have begun after the start of employment. Informa-
tion on job titles and tasks was not available in Denmark, so all 
workers in that subcohort were assigned to an unspecified job 
category presumed to involve exposure to styrene.
Quantitative exposure to styrene was estimated from approx-
imately 11 600 personal measurements of styrene in air in the 
years 1970–1990. In those cases when multiple measurements 
were available for a worker, they were combined to estimate 
the time-weighted average. Mean styrene concentrations were 
estimated according to country, job, product and time period 
and entered into a job-exposure matrix (JEM), which was then 
linked to full individual work histories. An analysis of about 18 
000 measurements of mandelic and phenoglyoxylic acid, the 
main styrene metabolites in urine, supported the development 
of the JEM.23 Because exposure data for years before 1970 were 
only available for Denmark, exposures in other countries during 
earlier years were estimated by extrapolation.12 In those coun-
tries, the average styrene concentration was assumed to have 
been 200 ppm, as observed in Denmark, until 1965 and then to 
decline linearly to the arithmetic mean of the earliest measure-
ments in each country.
data analysis
We analysed associations of mortality from the selected cancers 
with indicators of exposure to styrene using the ungrouped form 
of Poisson regression, equivalent to the discrete-time hazard 
model24 25 to estimate adjusted rate ratios (RRs) and likeli-
hood-based 95% CIs. Follow-up time was treated as the time 
axis, with each observation representing one person-year of 
experience or a fraction thereof in the case of censoring during 
the year. For each type of cancer, we first evaluated demographic 
and occupational predictors including age at risk, calendar time, 
sex, country, length of follow-up and time since first exposure. to 
develop a base model that best fit the mortality data as assessed 
by the Akaike information criterion (AIC). Age, calendar time, 
sex and country were entered in categorical form, while length 
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of follow-up and time since first exposure were treated as contin-
uous linear variables. We evaluated the effect of each covariate 
on the association of cancer mortality with styrene exposure and 
any that appreciably changed the RR were retained. Different 
covariates could thus be selected according to the outcome, 
resulting in a final model that estimated parameters for indica-
tors of exposure to styrene adjusted for those factors.
The exposure indicators evaluated included employment 
in exposed jobs, employment as a laminator (the job with the 
highest average exposure to styrene), duration in exposed jobs, 
cumulative styrene exposure (ppm-years) and mean styrene 
concentration (ppm) in exposed jobs. Cumulative and mean 
styrene exposure were entered as continuous variables assuming 
a model of form ln(RR) = βX +γP in which the natural log of 
the RR is linearly related to the level of styrene exposure, X, 
and a vector of other demographic and occupational predictor 
variables, P. To investigate potential latency effects, we evaluated 
cumulative and mean exposure lagged by 0, 5, 10 and 20 years 
for lymphohaematopoietic cancers and by 0, 10 and 20 years for 
other cancers.
To further investigate the shape of the exposure–response 
function for lung cancer, which had the largest number of 
deaths, we conducted additional analyses in which exposure was 
smoothed with penalised splines. The fit of alternative models 
was assessed using the likelihood ratio χ2 for the exposure terms.
Analyses using log-linear models were performed in Stata and 
models using smoothed terms were fit in R.26
resulTs
Descriptive data for the full cohort, including Norway, have 
already been published12 and have not substantially changed. After 
reconstructing the analysis files, correcting errors and excluding 
data from Norway, this reanalysis included 37 021 workers, who 
contributed approximately 506 459 person-years of follow-up 
experience, during which 2351 had died. In the cohort with 
Norway excluded, the mean duration of employment was 3.1 
years and workers spent an average of 2.2 years in jobs exposed 
to styrene. The arithmetic mean concentration of styrene during 
employment in these jobs was approximately 63 ppm, resulting in 
an arithmetic mean cumulative exposure of about 158 ppm-years 
per worker (table 1). Exposed and unexposed workers within the 
cohort had similar mortality for all causes and all cancer (RR 1.01, 
95% CI 0.89 to 1.14 and 1.01, 95% CI 0.81 to 1.17, respectively) 
(online supplementary table S2).
Mortality rates for the cancers of prior interest were not signifi-
cantly increased among all workers who held jobs involving expo-
sure to styrene compared with unexposed workers (table 2). RRs 
were 3.50 (95% CI 0.46 to 26.82) and 1.85 (95% CI 0.81 to 
6.15) for oesophageal cancer and prostate cancer, respectively, 
and near or below unity for all other cancers, including NHL 
and myeloid leukaemia.
Among laminators, RRs were elevated for cancer of the 
oesophagus (RR 2.71, 95% CI 1.00 to 7.37), pancreas (RR 1.18, 
95% CI 0.53 to 2.61) and prostate (RR 1.85, 95% CI 0.64 to 
5.36).
Mortality from NHL (RR 1.40, 95% CI 0.51 to 3.79) and 
cancer of the pancreas (RR 2.12, 95% CI 0.93 to 4.38) was 
increased among workers employed 2 to <5 years in exposed 
jobs relative to workers exposed for <2 years (table 2), but 
no consistent increase in mortality from those cancers was 
observed among workers exposed >5 years. Oesophageal cancer 
mortality was increased in workers exposed for ≥2 years (RR 
1.80, 95% CI 0.62 to 45.22), but there were too few deaths for 
analysis of longer exposure duration. Mortality from cancers 
of the lung (RR 1.14, 95% CI 0.80 to 1.62) and prostate (RR 
1.35, 95% CI 0.57 to 3.16) was increased only among workers 
employed ≥5 years. For lung cancer, which had the largest 
number of deaths (231), we also considered longer exposure 
durations of 5 to <10, 10 to <20 and ≥20 years; the RRs in 
these categories were 1.02 (95% CI 0.65 to 1.60), 1.29 (95% 
CI 0.77 to 2.15) and 1.56 (95% CI 0.49 to 4.97), respectively. 
There were no significant trends in mortality from any cancer 
with the duration of exposure to styrene (table 2). For cancers of 
the kidney and bladder, the RRs for all of the exposure metrics 
considered were near unity or below.
We analysed exposure–response relationships of styrene 
with mortality from total NHL (including multiple myeloma), 
multiple myeloma, myeloid leukaemia and lung cancer, which 
were of prior interest, and with cancers of the oesophagus, 
pancreas and prostate, as they had adequate numbers for analysis 
and indications of associations with employment in exposed jobs 
and exposure duration.
For NHL, the RR was 1.02 or 1.03 per 100 ppm-years of 
cumulative exposure to styrene for lag periods of 0, 5 and 10 
years and was not statistically significant (table 3). However, 
NHL mortality was significantly associated with mean styrene 
concentration in exposed jobs (RR 2.31, 95% CI 1.29 to 4.12 
per 100 ppm with a 0-year lag). Multiple myeloma was non-sig-
nificantly associated with cumulative styrene exposure with a 
10-year lag and with mean styrene exposure for all lag intervals 
(table 3). Myeloid leukaemia was not associated with cumulative 
styrene exposure, while RRs were non-significantly increased 
with increasing mean exposure (table 3).
Table 1 International Agency for Research on Cancer cohort of 
reinforced plastics workers exposed to styrene, 1945–1991, cohort 
characteristics
n %* Person-years
All workers 37 021 100 506 459
Men 31 692 85 428 006
Women 5692 15 78 453
Exposed job 31 803 85 407 459
  Laminators 8946 24 132 062
Unexposed job 3797 11 66 412
Unknown job 1833 5 32 705
Employment duration (years)
  <2 22 865 62 307 521
  2 to <5 5583 15 82 698
  ≥5 7086 19 95 895
  Unknown 1487 4 20 345
Exposure duration (years)
  <2 24 715 67 339 328
  2 to <5 4593 12 64 646
  ≥5 y 5075 14 61 514
  Unknown 2638 7 40 971
Mean range
Mean employment duration (years) 3.1 <0.01–62.0
Mean exposure duration (years) 2.2 0–33.5
Mean length of follow-up (years) 12.8 0–45.0
Mean styrene exposure (ppm) 63.1 0–205.0
Mean cumulative styrene exposure 
(ppm-years)
158.0 0–4543.1
*Per cents may not add to 100 because of rounding.
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Lung cancer mortality was not associated with any quanti-
tative measure  of styrene exposure (table 4). Mortality from 
oesophageal cancer was significantly associated with cumulative 
styrene and mean styrene exposure lagged 20 years (RRs 1.16, 
95% CI 1.03 to 1.31 per 100 ppm-years and RR 3.36, 95% CI 
1.74 to 6.49 per 100 ppm, respectively). Mortality from cancer 
of the pancreas increased significantly with unlagged mean 
styrene exposure (RR 1.89, 95% CI 1.17 to 3.06 per 100 ppm), 
but not with cumulative exposure. Mortality from cancer of the 
prostate showed a similar pattern of a non-significant increase 
with higher unlagged mean exposure, but no association with 
cumulative exposure (table 4).
For lung cancer mortality and cumulative exposure to styrene, 
we also investigated the shape of the exposure–response func-
tion using non-parametric spline models. These models did not 
fit the data better, as assessed by AIC, than parametric models 
with cumulative exposure entered as a linear term, however 
(illustrative data shown in online supplementary figure S1).
We conducted additional analyses to assess the effects on the 
results of uncertainties in estimating exposure to styrene. To gauge 
potential misclassification due to the lack of detailed occupational 
histories for workers in Denmark, we repeated the principal anal-
yses excluding that subcohort. To evaluate potential bias due to the 
lack of quantitative exposure data for years before 1970 in coun-
tries other than Denmark, we performed two additional exposure–
response analyses. One used alternative exposure estimates based 
on an assumption that styrene concentrations in the period when 
no data were available were equal to the earliest measured concen-
trations in each country12 and another included only workers first 
exposed after 1970. Among the latter group of workers first exposed 
in later years, lung cancer mortality was significantly associated with 
cumulative styrene exposure (RR 1.11, 95% CI 1.02 to 1.20) and 
non-significantly increased with mean exposure (RR 1.26, 95% CI 
0.76 to 2.07). None of the other analyses gave results materially 
different from those based on the full cohort or the primary expo-
sure model for any cancer, although the exclusions reduced the 
precision of most risk estimates (online supplementary table S3).
dIsCussIOn
In this reanalysis of an international cohort of workers exposed 
to styrene in the glass-reinforced plastics industry, mortality 
Table 2 Cancer mortality by job and exposure duration, International Agency for Research on Cancer cohort of reinforced plastics workers exposed 
to styrene, 1945–1991
Cancer (number 
of deaths)
unexposed 
jobs* exposed jobs laminators
exposed
<2years exposed 2<5 years exposed≥5 years P-trend†
n rr n rr‡ 95% CI‡ n rr 95% CI n rr n rr 95% CI n rr 95% CI
NHL (29)§ 5 1.00 22 1.01 0.37 to 2.74 6 0.98 0.40 to 2.42 17 1.00 5 1.40 0.51 to 3.79 5 0.92 0.34 to 2.54 0.78
Multiple myeloma 
(8)
2 1.00 8 1.05 0.20 to 5.37 0 0 – 7 1.00 3¶ 0.77 0.20 to 3.00 1 – – 0.23 
Myeloid leukaema 
(15)**
2 1.00 12 0.57 0.09 to 3.49 1 0.19 0.01 to 3.49 10 1.00 4¶ 0.53 0.14 to 1.94 3 – – 0.53 
Lung (231) 48 1.00 159 0.85 0.57 to 1.19 49 0.88 0.62 to 1.25 144 1.00 26 0.94 0.62 to 1.42 42 1.14 0.80 to 1.62 0.43
Oesophagus (16) 1 1.00 15 3.50 0.46 to 26.82 7 2.71 1.00 to 7.37 8 1.00 6¶ 1.80 0.62 to 5.22 4 – – 0.20
Pancreas (35) 7 1.00 27 1.06 0.46 to 2.46 8 1.18 0.53 to 2.61 19 1.00 8 2.12 0.93 to 4.38 7 1.33 0.56 to 3.19 0.65
Bladder (25) 3 1.00 21 0.92 0.22 to 3.80 3 0.88 0.22 to 3.50 18 1.00 3 0.72 0.21 to 2.46 3 0.54 0.15 to 1.94 0.57
Kidney (13) 2 1.00 9 0.83 0.18 to 3.99 3 0.88 0.21 to 3.71 7 1.00 4¶ 1.08 0.31 to 3.78 2 – – 0.90
Prostate (33) 5 1.00 27 1.85 0.64 to 5.36 5 1.36 0.47 to 3.89 22 1.00 4 0.92 0.32 to 2.70 7 1.35 0.57 to 3.16 0.77
*Missing and unknown jobs excluded.
†P for continuous linear variable.
‡RRs adjusted as follows: NHL, lung cancer, bladder cancer: age, calendar decade, country, sex; multiple myeloma: age, calendar decade, sex; myeloid leukaemia: age, sex, 
country; kidney cancer: age, calendar decade, sex; prostate cancer: age, country; pancreatic cancer, oesophageal cancer: age.
§Includes multiple myeloma.
¶Exposure duration ≥2 years.
**Includes acute and chronic myeloid leukaemia.
NHL, non-Hodgkin’s lymphoma; RR, rate ratio. 
Table 3 Mortality from lymphohaematopoietic cancers and estimated exposure to styrene, International Agency for Research on Cancer cohort of 
reinforced plastics workers exposed to styrene, 1945–1991
nHl (n=24) Multiple myeloma (n=8) Myeloid leukaemia* (n=15)
rr† 95% CI† AIC rr 95% CI AIC rr 95% CI AIC
Cumulative styrene exposure (100 ppm-years)
  0-year lag 1.02 0.94 to 1.10 488.2 0.82 0.54 to 1.26 179.7 0.90 0.73 to 1.10 314.6
  5-year lag† 1.02 0.94 to 1.11 488.2 0.87 0.59 to 1.27 180.3 0.91 0.73 to 1.12 315.1
  10-year lag 1.03 0.94 to 1.12 488.1 1.69 0.30 to 1.62 179.5 0.88 0.66 to 1.17 315.0
Mean styrene exposure (100 ppm)
  0-year lag 2.31 1.29 to 4.12 480.3 1.86 0.71 to 4.86 179.6 0.92 0.37 to 2.32 316.1
  5-year lag† 2.29 1.33 to 3.93 479.6 2.25 0.92 to 5.48 178.1 1.34 0.61 to 2.94 315.6
  10-year lag 1.78 1.05 to 3.02 484.2 1.31 0.48 to 3.58 180.9 1.50 0.71 to 3.17 315.1
*Includes acute myeloid leukaemia and chronic myeloid leukaemia.
†RR per 100 ppm-year or 100 ppm; RRs adjusted as follows: NHL, multiple myeloma, age, calendar decade, sex; myeloid leukaemia, age, calendar year, sex, country.
AIC, Akaike information criterion; NHL,  non-Hodgkin’s lymphoma; RR, rate ratio. 
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from NHL and cancers of the oesophagus, pancreas and prostate 
showed associations with the employment in exposed jobs or the 
duration of such employment, but effect estimates were impre-
cise and trends with duration were not statistically significant.
Increased mortality from lympohaematopoietic cancers, 
including NHL, has also been reported in several industrial 
cohorts3–11 as well as a previous analysis of this cohort which 
showed associations with the metrics of time since first expo-
sure and average level of exposure to styrene, but not with 
duration of exposure or cumulative exposure.12 However, these 
prior studies used various definitions of NHL that have been 
superseded by the current WHO definition. In this reanalysis, 
NHL was defined by regrouping ICD codes for lymphomas and 
leukaemias from the original study following the current WHO 
classification, which now includes multiple myeloma and acute 
and chronic lymphatic leukaemia.20 We did not have the detailed 
information needed to identify B-cell and T-cell lymphomas 
or other NHL subtypes that did not have codes in the 8th and 
9th revisions of the ICD. This regrouping yielded associations 
of styrene exposure and NHL mortality that were essentially 
similar to those in the original analysis of the cohort.12
We found statistically significant associations of oesophageal 
cancer with cumulative and mean styrene exposure and of pancre-
atic cancer with mean styrene exposure that were not seen in the 
less detailed exposure–response analysis in the previous paper.12
No clear increase in mortality from lung or bladder cancer 
with exposure to styrene was observed in this reanalysis or in 
the original analysis,12 but we did find increased lung cancer risk 
among workers employed >10 years and among those hired 
after 1970. Excess risk of lung and bladder cancers has been 
reported in other studies,7 14 15 19 22 including in updated data for 
components of this cohort from Denmark and the UK.16 17 Given 
that these reports were based on extended follow-up of cohorts 
enumerated around the same time as the one we studied, it is 
possible that longer follow-up is needed to observe any increase 
in lung cancer mortality.
Inconsistencies in reported results between publications may be 
due to several factors. Some previous studies may have been under-
powered to detect an effect as they examined cancer mortality 
in industries where levels of exposure to styrene are fairly low. 
Furthermore, co-exposures to known or suspected carcinogens 
may have occurred, resulting in spurious findings. For example, 
workers in the styrene-butadiene rubber industry may have signif-
icant exposures to 1,3-butadiene, while workers involved in 
styrene production and polymerisation may be exposed to diverse 
chemicals, including benzene.5 7 Benzene and 1,3-butadiene are 
recognised causes of leukaemia, and positive associations with 
NHL have been seen in some studies.27
A strength of this study is that it was based on observations 
of >37 000 workers, most of whom were exposed to styrene 
without significant exposures to other carcinogens. Acetone 
is the most frequent chemical co-exposure encountered in the 
reinforced plastics industry,28 but is not known or suspected to 
be carcinogenic.29 The presence of dichloromethane (arithmetic 
mean concentration 51 mg/m3) was reported in a study of Danish 
industries, including reinforced plastics, that used styrene in the 
period 1955–1988; perchloroethylene and trichloroethylene 
were also detected in a small number of samples, but the concen-
trations were very low.28 Styrene 7,8-oxide has been detected 
more recently in the air of reinforced-plastic manufacturing 
workshops,30 but no measurements were available for the facil-
ities included in this study. Workers involved in the lamina-
tion process may also have been exposed to man-made fibres, 
including continuous glass filaments; although no data on expo-
sure levels were available for the cohort, previous studies have 
not demonstrated a link with cancer.31
Moreover, several previous studies were unable to account 
for potential confounding by non-occupational risk factors, 
notably tobacco smoking, as no information was collected at 
the individual level and analyses were based on SMRs with the 
general population as a referent group. Although information 
on tobacco smoking and other personal risk factors was also 
lacking for our international cohort, concerns about potential 
confounding by non-occupational risk factors are reduced in our 
analyses with an internal referent group of unexposed or less 
exposed workers.
Other limitations of this study include the deletion of data from 
Norway, which modestly reduced precision for some estimates, 
the relatively short duration of employment in the industry and of 
follow-up (approximately 3 and 13 years, respectively, on average) 
and small numbers of deaths for some of the cancers of interest. 
Approximately 60% workers in our study were employed <2 
years, reflecting the typical employment pattern in the industry.12 
The observed tendency for several cancers to be associated with 
mean, but not cumulative styrene exposure may be related to the 
short duration of exposure for most workers, which would mini-
mise contrast in cumulative exposure. Given the high proportion 
of short-term workers, healthy worker survivor bias could be a 
potential explanation for the observation that the risk estimates 
for NHL and cancers of the pancreas and prostate were higher in 
workers who were exposed to styrene 2–5 years relative to those 
exposed for ≥5 years.
Table 4 Cancer mortality and estimated exposure to styrene, International Agency for Research on Cancer cohort of reinforced plastics workers 
exposed to styrene, 1945–1991
lung Oesophagus Pancreas Prostate
rr* 95% CI AIC rr 95% CI AIC rr 95% CI AIC rr 95% CI AIC
Cumulative styrene exposure (100 ppm-years)
  0-year lag 1.02 0.99 to 1.05 3099 1.06 0.97 to 1.16 298.6 1.03 0.97 to 1.10 612.4 1.03 0.96 to 1.10 538.5
  10-year lag 1.03 0.99 to 1.06 3099 1.08 0.98 to 1.19 298.2 1.03 0.96 to 1.11 612.6 1.00 0.92 to 1.10 539.2
  20-year lag 1.00 0.91 to 1.09 3100 1.16 1.03 to 1.31 296.8 1.01 0.84 to 1.22 613.2 0.97 0.76 to 1.23 539.2
Mean styrene exposure (100 ppm)
  0-year lag 0.98 0.79 to 1.22 3100 2.44 1.11 to 5.36 294.8 1.89 1.17 to 3.06 606.4 1.26 0.76 to 2.11 538.3
  10-year lag 0.97 0.80 to 1.18 3100 2.53 1.30 to 4.90 293.0 1.31 0.82 to 2.10 611.9 1.03 0.64 to 1.68 539.2
  20-year lag 0.81 0.59 to 1.12 3101 3.36 1.74 to 6.49 290.9 1.14 0.57 to 2.28 613.1 1.07 0.55 to 2.10 539.2
*RR per 100 ppm-year or 100 ppm. RRs adjusted as follows: NHL, age, calendar decade, sex; lung cancer, age, sex, country; oesophageal cancer, pancreatic cancer: age; prostate 
cancer: age, country.
AIC, Akaike  information criterion; NHL, non-Hodgkin’s lymphoma;  RR,  rate ratio. 
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Workplace
It is also possible that some risk estimates were affected by 
exposure measurement error. Because all workers in Denmark 
were assigned to an unspecified job category presumed to involve 
exposure to styrene, up to one-fourth of the workers classified as 
styrene exposed may have actually been unexposed. However, 
analyses excluding Denmark gave similar results, so the impact 
of this potential source of error appears to have been minimal. 
It is also possible that heavily exposed short-term workers were 
excluded from the cohort because early payroll records (used to 
classify workers with respect to styrene exposure) were not avail-
able from all of the 660 plants for various reasons.12 The estima-
tion of exposure before 1970 by extrapolating from measurements 
in Denmark is another potential source of information bias. If the 
actual exposures during that time were higher than the extrapo-
lated estimates, then estimated RRs would be biased towards the 
null, while if they were lower, the RRs would be biased upwards.
COnClusIOn
This reanalysis using a modern definition of NHL and a more 
detailed analytical approach does not substantially change the 
conclusions of the original study with respect to the associations 
of NHL and lung cancer with exposure to styrene: NHL mortality 
was associated with mean career styrene exposure, while lung 
cancer was not associated with any indicator of styrene exposure 
in the full cohort. However, we found suggestive new evidence 
that increased mortality from cancer of the pancreas is associ-
ated with employment in exposed jobs and with average styrene 
concentration and that cancer of the oesophagus is associated with 
cumulative styrene exposure, as well as with these indicators. More 
information about the associations of these cancers with exposure 
to styrene would be valuable in light of the inconsistent results of 
other studies. A full update of cancer mortality in this cohort would 
be informative, but may not be feasible. New studies and updated 
analyses of populations occupationally and environmentally 
exposed to styrene are therefore warranted. Ideally, such studies 
would be based on cancer incidence data, which would improve 
the identification and classification of leukaemias and lymphomas.
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